DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the field of biopharmaceuticals, providing promising improvements throughout various clinical and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, additional trusted alternative for therapeutic use, sp